Figure 2. Baseline symptom endorsement by genotype in at-risk family members.
Percentage of preclinical and non-mutation carriers that endorse each of the sub-symptoms identified as the most frequent symptom in symptomatic patients
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.